4//SEC Filing
GENEREX BIOTECHNOLOGY CORP 4
Accession 0001144204-08-021453
CIK 0001059784operating
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 5:04 PM ET
Size
7.6 KB
Accession
0001144204-08-021453
Insider Transaction Report
Form 4
BERNSTEIN GERALD
VP, Medical Affairs
Transactions
- Exercise/Conversion
Common Stock Option (right to buy)
2008-04-08−50,000→ 0 totalExercise: $1.00From: 2003-03-19Exp: 2008-04-18→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2008-04-08$1.00/sh+50,000$50,000→ 53,469 total
Footnotes (1)
- [F1]Exercise of an option to purchase 50,000 shares of common stock of the Issuer which was issued to the Reporting Person under the Generex Biotechnology Corporation Amended 2001 Stock Option Plan and the terms of the agreement entered into by and between the Issuer and the Reporting Person dated as of April 1, 2002, as amended to date, relating to the Reporting Person's employment as the Issuer's Vice President, Medical Affairs. The option was initially granted to the Reporting Person on March 19, 2003. The initial expiration date of the option, March 19, 2008, was extended to April 18, 2008 by the Issuer's Board of Directors.
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001059784
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 5:04 PM ET
- Size
- 7.6 KB